Evidence map›Paper›PMID 31781309›Full record

ArticleDisease markers2019

Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.

Bin Chen, Wei Chen, Jing Jin, Xueping Wang, Yifang Cao, Yi He

Abstract read
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bin ChenUrology Department, Jiaxing First Hospital, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhenjiang 314001, China.
Wei ChenUrology Department, Jiaxing First Hospital, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhenjiang 314001, China.
Jing JinUrology Department, Jiaxing First Hospital, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhenjiang 314001, China.
Xueping WangUrology Department, Jiaxing First Hospital, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhenjiang 314001, China.
Yifang CaoUrology Department, Jiaxing First Hospital, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhenjiang 314001, China.ORCID https://orcid.org/0000-0001-6052-1412
Yi HeUrology Department, Jiaxing First Hospital, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhenjiang 314001, China.ORCID https://orcid.org/0000-0002-4688-2737

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent kidney malignancies. The tumor microenvironment (TME) is highly related to the oncogenesis, progress, and prognosis of ccRCC. The aim of this study was to infer the level of infiltrating stromal and immune cells and assess the prognostic value of them. The gene expression profile was obtained from TCGA and used for calculating the stromal and immune scores. Based on a cut-off value, patients were divided into low- and high-stromal/immune score groups. Survival analysis was performed to evaluate the prognostic value of stromal and immune scores. Moreover, differentially expressed genes (DEGs) that are highly related to TME were determined and applied for functional enrichment analysis and protein-protein interaction (PPI) network. The Kaplan-Meier plot demonstrated that patients with high-immune scores and stromal scores had poorer clinical outcome. In addition, a total of 89 DEGs were identified and mainly involved in 5 pathways. The top 5 degree genes were extracted from the PPI network; among them, IL10 and XCR1 were highly associated with prognosis of ccRCC. The results of the present study demonstrated that ESTIMATE algorithm-based stromal and immune scores may be a credible indicator of cancer prognosis and IL10 along with XCR1 may be a potential key regulator for the TME of ccRCC.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticAgedBiomarkers, TumorCarcinoma, Renal CellData MiningFemaleGene Regulatory NetworksHumansKidney NeoplasmsMalePrognosisSurvival RateTranscriptomeTumor MicroenvironmentBiomarkers, Tumor

Identifiers

PMID31781309
PMCPMC6875323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.